Teams edit genes inside human cells

Independent teams demonstrated that CRISPR-Cas9 could edit selected genes inside mammalian, including human, cells. Moving from purified molecules into living cells rapidly expanded its usefulness for studying gene function, building disease models and exploring agricultural and medical applications. It also exposed practical problems such as delivery, unintended edits and variable results, all of which matter before clinical use.